What is ComboCap?
ComboCap, Inc., operating as ComboCap Health, is a South African-founded company that launched in the U.S. in 2012 after seven years of global research and development. The company specializes in creating a novel category of combination therapies through its patented ComboCap® product. This innovative dual-chamber capsule allows for the simultaneous delivery of wet and dry components, enabling pharmaceutical and nutraceutical industries to develop combination products previously unachievable. ComboCap owns all manufacturing rights, trademarks, and holds international patents for its unique design, machinery, and process.
How much funding has ComboCap raised?
ComboCap has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for ComboCap?
With substantial late-stage funding, ComboCap is poised for significant scaling and market penetration. The strategic investment suggests a focus on expanding manufacturing capabilities, accelerating commercialization efforts, and potentially forging key partnerships within the pharmaceutical and nutraceutical value chains. The company's proprietary technology offers a unique value proposition, positioning it for growth as demand for advanced combination therapies increases.
See full ComboCap company page
